0
0
Roche will provide funding, technical support and global platforms for visibility while ASLM will lead country-level implementation, stakeholder coordination and curriculum development
- The partnership dubbed, Leadership Excellence for African Diagnostics (LEAD) between Roche and ASLM is a three-year programme to strengthen lab leadership in Africa
- The initiative focuses on mentorship and training to build lab leadership capabilities
Roche Diagnostics Africa (www.Roche.com) and the African Society for Laboratory Medicine (ASLM) (www.ASLM.org) have announced the launch of a three-year partnership to elevate laboratory leadership and improve access to quality diagnostic services across the continent. The initiative — titled LEAD: Leadership Excellence for African Diagnostics — brings together health ministries, laboratory directors, academic partners and technical experts to develop a new generation of capable, connected and future-ready lab leaders.
” This partnership will build long-term leadership that would shape the future of diagnostics in Africa — practically, strategically and sustainably “
“This partnership will build long-term leadership that would shape the future of diagnostics in Africa — practically, strategically and sustainably. In a time where we need African healthcare systems to become less reliant on external funding sources, we are focused on increasing domestic diagnostics capacity more than ever,” says Dr Allan Pamba, Executive Vice President, Diagnostics, Africa, at Roche Diagnostics.
“We are entering a new chapter where African health systems take the lead in their own transformation. By growing diagnostic leadership we support long-term resilience and impact. LEAD equips professionals who can influence policy, drive national strategy and build sustainable healthcare capacity.”
Under the partnership, LEAD will deliver a series of integrated interventions including baseline leadership assessments to guide a tailored context-specific training approach, development of a pan-African curriculum in collaboration with a leading academic institution, structured mentorship and professional development for emerging lab leaders, peer learning and regional collaboration through workshops and best practise exchanges.
ASLM Chief Executive Officer, Nqobile Ndlovu, added: “Diagnostics are the foundation of resilient health systems – but strong labs require strong leaders. LEAD focuses on people: their vision, their reach and their ability to transform public health from within. With this programme, we are supporting the leadership needed to move African healthcare forward.”
Roche will provide funding, technical support and global platforms for visibility while ASLM will lead country-level implementation, stakeholder coordination and curriculum development.
Laboratory strengthening is a key enabler for stronger health systems and this partnership is a commitment towards a healthier future for Africans.
About Author
OTHER ARTICLES
Lusaka — African health ministers and partners are calling for increased investment in integrated health services to address the growing burden of severe noncommunicable diseases (NCDs), particularly those affecting women and underserved populations across the region. At a high-level side event during the Seventy-fifth session of the WHO Regional Committee for Africa, delegates emphasized the urgent need for equitable access to prevention, screening, treatment, and rehabilitation across the continuum of care for NCDs. Disparities are especially pronounced in rural areas, where health infrastructure and services remain inadequate. Breast and cervical cancers are among the leading causes of cancer-related deaths among women in sub-Saharan Africa—particularly cervical cancer, which is both preventable and treatable. It remains the most common cause of cancer death for women in the region. In 2022, Africa accounted for nearly a quarter (23%) of the 76 000 global cervical cancer deaths. Meanwhile, severe NCDs such as Type 1 diabetes, sickle cell disease, and heart conditions claim more than half a million lives annually, including among children, adolescents, and young adults in some of the continent’s poorest communities. Inequitable access to health services continues to hinder efforts to reduce this burden. To improve cervical and breast cancer care in the region, urgent investment is needed in leadership, governance, and financing. Strengthening these foundations is critical in the current funding landscape. Advancements in strategic planning, healthcare infrastructure, workforce training, and—most importantly—equitable access to screening, diagnostic, and treatment services are essential. To address these challenges, WHO and its partners showcased successful integrated models such as the Women’s Integrated Care for Cancer Services (WICS), the BEAT Breast Cancer Project, and the PEN-Plus Strategy. WICS strengthens early detection, treatment, and integration of women’s cancer services into primary health care systems in Côte d’Ivoire, Kenya, and Zimbabwe. The BEAT Breast Cancer Project is a transformative multi-year initiative aimed at reducing breast cancer mortality among women in Tanzania and Ghana through early detection, timely diagnosis, and comprehensive treatment access. “PEN-Plus, WICS and the BEAT Breast Cancer Initiative are models for a new standard of care, rooted in equity, access and health justice. I urge countries to prioritize policies that embed these models into broader health system strengthening, said Dr Mohamed Janabi, WHO Regional Director for Africa”. Côte d’Ivoire offers a compelling example of progress, combining high HPV vaccination coverage—reaching over three million girls (91.4%)—with WICS-supported community-based screening campaigns to strengthen cervical cancer prevention. In Kenya, cervical cancer screening has been successfully integrated into national health services. “This gathering marks a pivotal moment to accelerate action for breast cancer prevention in Africa. We deeply value the leadership of the Ministries of Health of Ghana and Tanzania, and the steadfast support of the Pfizer Foundation in helping us achieve this milestone. The side event builds momentum for the policy prioritization of women’s cancers, partnerships to strengthen the broader women’s cancer ecosystem, and advance a health-systems approach to breast cancer prevention and management”, said Dr Somesh Kumar, Senior Director, Jhpiego. PEN-Plus expands access to care for severe NCDs at the district hospital level. Since its implementation, 20 countries in Africa have increased access to services for severe NCDs. Over 15 000 people are currently receiving treatment for chronic conditions such as sickle cell disease and Type 1 diabetes through PEN-Plus clinics.
Confirmed Case of Mpox in Senegal: Situation Update (as of August 27, 2025)
African health ministers adopt strategy to strengthen rehabilitation services in health care